NervGen Pharma Corp. , a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, today announced the appointment of John Ruffolo,.
Network Joins Over 100 Companies to Deliver AI-Enabled Solutions to Enterprises WorldwideTORONTO, ON / ACCESSWIRE / January 18, 2022 / EQ Inc. (TSXV:EQ) ("EQ Works" or "EQ"), a leader in geospatial data